Wall Street analyst estimates for Atlantic International Corp. (ATLN): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Based in Billerica, Massachusetts, and established in 2013, Atlantic International Corp. (which operated as SeqLL Inc. until its name change in June 2024) underwent a significant corporate change on June 18, 2024, when it was acquired by Lyneer Investments, LLC, via a reverse merger. The company operates within the life sciences sector, providing specialized instrumentation and research services.
Valuation Ratios
| Price / Book | 7.10 |
| EV / EBITDA | -3.31 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $939682 | $1.3M | $779068 | $533129 | $329495 | $425.0M | $441.5M | $401.4M | $442.6M | $435.9M |
| Cost of Revenue | $520095 | $1.1M | $674281 | $219763 | $170803 | $370.6M | $387.3M | $354.5M | $395.4M | $389.9M |
| Gross Profit | $419587 | $254234 | $104787 | $313366 | $158692 | $54.4M | $54.2M | $46.9M | $47.2M | $46.0M |
| Research & Development | $1.1M | $974531 | $1.0M | $1.2M | $330979 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $690982 | $806897 | $1.5M | $1.4M | $777435 | $42.2M | $42.3M | $45.4M | $64.0M | $91.3M |
| Operating Expenses | $1.8M | $1.8M | $2.5M | $2.6M | $1.1M | $90.1M | $48.2M | $50.3M | $69.0M | $96.2M |
| Operating Income | -$1.4M | -$1.5M | -$2.4M | -$2.3M | -$949720 | -$35.7M | $6.0M | -$3.5M | -$21.8M | -$50.2M |
| EBITDA | -$1.3M | -$1.5M | -$2.6M | -$2.2M | -$649393 | $12.2M | $11.9M | $1.4M | -$113.1M | -$43.6M |
| Interest Expense | $50740 | $179740 | $230296 | $182250 | $287197 | $208289 | $90748 | $17.5M | $12.0M | $9.2M |
| Pre-tax Income | -$1.4M | -$1.7M | -$2.9M | -$2.5M | -$1.0M | -$39.5M | -$2.4M | -$21.2M | -$130.1M | -$59.4M |
| Income Tax | -$2 | $4 | -$4 | 0 | 0 | $1.3M | $808430 | -$5.9M | $5.4M | $33991 |
| Net Income | -$1.4M | -$1.7M | -$2.9M | -$2.5M | -$1.0M | -$40.8M | -$3.2M | -$15.3M | -$135.5M | -$59.4M |
| EPS | $-0.09 | $-0.11 | $-0.14 | $-0.12 | $-0.05 | $-0.17 | $-0.19 | $-0.60 | $-3.68 | $-1.08 |
| EPS (Diluted) | $-0.09 | $-0.11 | $-0.14 | $-0.12 | $-0.05 | $-0.17 | $-0.17 | $-0.60 | $-3.68 | $-1.08 |
| Shares Outstanding (Diluted) | $15.6M | $15.6M | $21.3M | $21.3M | $21.3M | $21.7M | $24.1M | $25.4M | $36.8M | $54.8M |
Price
| Price | $0.90 |
| Market Cap | $73M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ASH.AX · CHZ.SI · CIRC · CWLPF · HQI · ILLR · IPDN
Explore sector: Healthcare · Medical - Pharmaceuticals
More sections of ATLN: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks